nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—ACHE—kidney cancer	0.958	1	CbGaD
Tubocurarine—SLC22A2—nephron—kidney cancer	0.000233	0.486	CbGeAlD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.63e-05	0.0016	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.61e-05	0.0016	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—BCHE—kidney cancer	6.58e-05	0.00159	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	6.52e-05	0.00157	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—MME—kidney cancer	6.48e-05	0.00156	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—RAF1—kidney cancer	6.43e-05	0.00155	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CCBL1—kidney cancer	6.36e-05	0.00153	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ACY1—kidney cancer	6.34e-05	0.00153	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—RAF1—kidney cancer	6.11e-05	0.00147	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—RPL14—kidney cancer	6.03e-05	0.00145	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—HSPD1—kidney cancer	6.03e-05	0.00145	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ACY1—kidney cancer	5.91e-05	0.00143	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—HIF1A—kidney cancer	5.91e-05	0.00143	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—BRAF—kidney cancer	5.9e-05	0.00142	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	5.79e-05	0.0014	CbGpPWpGaD
Tubocurarine—CHRNA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.75e-05	0.00139	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—PTEN—kidney cancer	5.6e-05	0.00135	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PPAT—kidney cancer	5.52e-05	0.00133	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GLIPR1—kidney cancer	5.52e-05	0.00133	CbGpPWpGaD
Tubocurarine—CHRNA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.47e-05	0.00132	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.45e-05	0.00131	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—APC—kidney cancer	5.4e-05	0.0013	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PDHB—kidney cancer	5.39e-05	0.0013	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.39e-05	0.0013	CbGpPWpGaD
Tubocurarine—CHRND—Neuronal System—MAPK1—kidney cancer	5.18e-05	0.00125	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—APRT—kidney cancer	5.13e-05	0.00124	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—FH—kidney cancer	5.13e-05	0.00124	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	5.11e-05	0.00123	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—kidney cancer	5.08e-05	0.00122	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CCBL1—kidney cancer	5.07e-05	0.00122	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	5.06e-05	0.00122	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PDHB—kidney cancer	5.02e-05	0.00121	CbGpPWpGaD
Tubocurarine—SLC22A2—nephron tubule—kidney cancer	5.02e-05	0.105	CbGeAlD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.01e-05	0.00121	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	4.95e-05	0.00119	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—RAF1—kidney cancer	4.93e-05	0.00119	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—EIF4EBP1—kidney cancer	4.91e-05	0.00119	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GPC3—kidney cancer	4.82e-05	0.00116	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—PAX6—kidney cancer	4.73e-05	0.00114	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CCBL1—kidney cancer	4.72e-05	0.00114	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CTSD—kidney cancer	4.71e-05	0.00114	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—BRAF—kidney cancer	4.7e-05	0.00113	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CA2—kidney cancer	4.69e-05	0.00113	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.69e-05	0.00113	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ALAD—kidney cancer	4.57e-05	0.0011	CbGpPWpGaD
Tubocurarine—SLC22A2—renal system—kidney cancer	4.56e-05	0.0953	CbGeAlD
Tubocurarine—ACHE—Neuronal System—BRAF—kidney cancer	4.52e-05	0.00109	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—OR4C13—kidney cancer	4.52e-05	0.00109	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	4.47e-05	0.00108	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ST3GAL2—kidney cancer	4.46e-05	0.00108	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	4.46e-05	0.00108	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	4.43e-05	0.00107	CbGpPWpGaD
Tubocurarine—SLC22A2—kidney—kidney cancer	4.41e-05	0.0921	CbGeAlD
Tubocurarine—CHRM2—GPCR ligand binding—ANXA1—kidney cancer	4.41e-05	0.00106	CbGpPWpGaD
Tubocurarine—CHRNA1—Neuronal System—MAPK1—kidney cancer	4.41e-05	0.00106	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GLIPR1—kidney cancer	4.39e-05	0.00106	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PPAT—kidney cancer	4.39e-05	0.00106	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—BRAF—kidney cancer	4.38e-05	0.00106	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ALDH1A1—kidney cancer	4.36e-05	0.00105	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—BCHE—kidney cancer	4.33e-05	0.00104	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	4.31e-05	0.00104	CbGpPWpGaD
Tubocurarine—SLC22A2—cortex of kidney—kidney cancer	4.3e-05	0.0897	CbGeAlD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—kidney cancer	4.24e-05	0.00102	CbGpPWpGaD
Tubocurarine—CHRNA2—Neuronal System—MAPK1—kidney cancer	4.19e-05	0.00101	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PGK1—kidney cancer	4.18e-05	0.00101	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SLC5A3—kidney cancer	4.18e-05	0.00101	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—LDHB—kidney cancer	4.1e-05	0.000989	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PPAT—kidney cancer	4.1e-05	0.000988	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GLIPR1—kidney cancer	4.1e-05	0.000988	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—APRT—kidney cancer	4.09e-05	0.000986	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—FH—kidney cancer	4.09e-05	0.000986	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—PIK3CA—kidney cancer	3.95e-05	0.000953	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—RAF1—kidney cancer	3.93e-05	0.000948	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.9e-05	0.00094	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LATS1—kidney cancer	3.84e-05	0.000927	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GPC3—kidney cancer	3.84e-05	0.000927	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—FH—kidney cancer	3.81e-05	0.000919	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—APRT—kidney cancer	3.81e-05	0.000919	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—RAF1—kidney cancer	3.78e-05	0.000911	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.75e-05	0.000905	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—RAF1—kidney cancer	3.74e-05	0.000902	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CA2—kidney cancer	3.74e-05	0.000902	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.69e-05	0.00089	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—RAF1—kidney cancer	3.66e-05	0.000883	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ALAD—kidney cancer	3.64e-05	0.000879	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.62e-05	0.000874	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—BRAF—kidney cancer	3.6e-05	0.00087	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.59e-05	0.000865	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GPC3—kidney cancer	3.58e-05	0.000864	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—POMC—kidney cancer	3.57e-05	0.000861	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—JUN—kidney cancer	3.56e-05	0.00086	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ST3GAL2—kidney cancer	3.55e-05	0.000858	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CA9—kidney cancer	3.55e-05	0.000858	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	3.54e-05	0.000853	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.51e-05	0.000846	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AKAP13—kidney cancer	3.5e-05	0.000844	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.5e-05	0.000843	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CA2—kidney cancer	3.48e-05	0.00084	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ALDH1A1—kidney cancer	3.47e-05	0.000838	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.47e-05	0.000838	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ALAD—kidney cancer	3.39e-05	0.000819	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.38e-05	0.000816	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.38e-05	0.000815	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—BRAF—kidney cancer	3.36e-05	0.000811	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—IGF2—kidney cancer	3.35e-05	0.000809	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PGK1—kidney cancer	3.33e-05	0.000804	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SLC5A3—kidney cancer	3.33e-05	0.000804	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.31e-05	0.000799	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ST3GAL2—kidney cancer	3.31e-05	0.000799	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AMER1—kidney cancer	3.27e-05	0.000789	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—LDHB—kidney cancer	3.27e-05	0.000788	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ALDH1A1—kidney cancer	3.24e-05	0.000781	CbGpPWpGaD
Tubocurarine—SLC22A1—renal system—kidney cancer	3.22e-05	0.0673	CbGeAlD
Tubocurarine—CHRM2—Signaling by GPCR—AKAP13—kidney cancer	3.18e-05	0.000767	CbGpPWpGaD
Tubocurarine—SLC22A1—kidney—kidney cancer	3.12e-05	0.0651	CbGeAlD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.11e-05	0.000751	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PGK1—kidney cancer	3.1e-05	0.000749	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SLC5A3—kidney cancer	3.1e-05	0.000749	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—kidney cancer	3.05e-05	0.000737	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—LDHB—kidney cancer	3.04e-05	0.000735	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.04e-05	0.000734	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CRABP1—kidney cancer	3.02e-05	0.000729	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—RAF1—kidney cancer	3.01e-05	0.000726	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ITPR2—kidney cancer	2.98e-05	0.000718	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.94e-05	0.000711	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—kidney cancer	2.91e-05	0.000701	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.86e-05	0.00069	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	2.84e-05	0.000685	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CA9—kidney cancer	2.83e-05	0.000683	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ITPR2—kidney cancer	2.81e-05	0.000678	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—RAF1—kidney cancer	2.8e-05	0.000677	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—kidney cancer	2.75e-05	0.000662	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GPC3—kidney cancer	2.74e-05	0.000661	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CER1—kidney cancer	2.74e-05	0.000661	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ITPR2—kidney cancer	2.7e-05	0.000652	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.69e-05	0.00065	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.67e-05	0.000643	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CA9—kidney cancer	2.64e-05	0.000637	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—MAPK1—kidney cancer	2.59e-05	0.000625	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.59e-05	0.000625	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTT1—kidney cancer	2.56e-05	0.000618	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	2.52e-05	0.000609	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.51e-05	0.000606	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—ANXA1—kidney cancer	2.49e-05	0.000602	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SCARB1—kidney cancer	2.43e-05	0.000585	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CRABP1—kidney cancer	2.41e-05	0.000581	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS1—kidney cancer	2.4e-05	0.000579	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PSMD7—kidney cancer	2.35e-05	0.000568	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SFRP2—kidney cancer	2.33e-05	0.000562	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—ANXA1—kidney cancer	2.26e-05	0.000546	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CRABP1—kidney cancer	2.24e-05	0.000542	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ITPR2—kidney cancer	2.24e-05	0.00054	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—POMC—kidney cancer	2.24e-05	0.00054	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—BCHE—kidney cancer	2.23e-05	0.000539	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SLC5A5—kidney cancer	2.2e-05	0.000532	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—POMC—kidney cancer	2.16e-05	0.000522	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SLC2A1—kidney cancer	2.13e-05	0.000514	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ITPR2—kidney cancer	2.09e-05	0.000503	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.07e-05	0.000498	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—MAPK1—kidney cancer	2.06e-05	0.000498	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ACHE—kidney cancer	2.04e-05	0.000493	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTT1—kidney cancer	2.04e-05	0.000493	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SCARB1—kidney cancer	1.93e-05	0.000466	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—MAPK1—kidney cancer	1.92e-05	0.000464	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS1—kidney cancer	1.91e-05	0.000462	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTT1—kidney cancer	1.9e-05	0.000459	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ACHE—kidney cancer	1.9e-05	0.000459	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP2—kidney cancer	1.88e-05	0.000453	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKAP13—kidney cancer	1.88e-05	0.000453	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PSMD7—kidney cancer	1.88e-05	0.000453	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.8e-05	0.000435	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SCARB1—kidney cancer	1.8e-05	0.000435	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS1—kidney cancer	1.78e-05	0.00043	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—BCHE—kidney cancer	1.78e-05	0.000429	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTP1—kidney cancer	1.78e-05	0.000429	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SLC5A5—kidney cancer	1.76e-05	0.000424	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PSMD7—kidney cancer	1.75e-05	0.000422	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GRB7—kidney cancer	1.72e-05	0.000414	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SLC2A1—kidney cancer	1.7e-05	0.000409	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ABCB1—kidney cancer	1.68e-05	0.000406	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—BCHE—kidney cancer	1.66e-05	0.0004	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SLC5A5—kidney cancer	1.64e-05	0.000395	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTM1—kidney cancer	1.63e-05	0.000394	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.62e-05	0.00039	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CTNNB1—kidney cancer	1.6e-05	0.000385	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ITPR2—kidney cancer	1.6e-05	0.000385	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SLC2A1—kidney cancer	1.58e-05	0.000382	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP1A1—kidney cancer	1.55e-05	0.000373	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.51e-05	0.000364	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	1.45e-05	0.000349	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	1.44e-05	0.000347	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HSPB1—kidney cancer	1.44e-05	0.000347	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTP1—kidney cancer	1.42e-05	0.000341	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ABCB1—kidney cancer	1.34e-05	0.000323	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.34e-05	0.000323	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.34e-05	0.000323	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.34e-05	0.000323	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTP1—kidney cancer	1.32e-05	0.000318	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTM1—kidney cancer	1.3e-05	0.000314	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.3e-05	0.000313	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.27e-05	0.000307	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ABCB1—kidney cancer	1.25e-05	0.000301	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP1A1—kidney cancer	1.23e-05	0.000297	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—POMC—kidney cancer	1.22e-05	0.000295	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTM1—kidney cancer	1.21e-05	0.000292	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PAK1—kidney cancer	1.2e-05	0.00029	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JUNB—kidney cancer	1.2e-05	0.00029	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—POMC—kidney cancer	1.15e-05	0.000278	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP1A1—kidney cancer	1.15e-05	0.000277	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—POMC—kidney cancer	1.11e-05	0.000268	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF2—kidney cancer	9.82e-06	0.000237	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	9.77e-06	0.000236	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IGF1R—kidney cancer	9.49e-06	0.000229	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS2—kidney cancer	9.2e-06	0.000222	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—POMC—kidney cancer	9.19e-06	0.000222	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—RAF1—kidney cancer	9.15e-06	0.000221	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—IL2—kidney cancer	9.03e-06	0.000218	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—POMC—kidney cancer	8.57e-06	0.000207	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL2—kidney cancer	8.2e-06	0.000198	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTEN—kidney cancer	8.02e-06	0.000194	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HIF1A—kidney cancer	7.81e-06	0.000189	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TSC2—kidney cancer	7.79e-06	0.000188	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KDR—kidney cancer	7.47e-06	0.00018	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS2—kidney cancer	7.33e-06	0.000177	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KIT—kidney cancer	6.88e-06	0.000166	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APC—kidney cancer	6.88e-06	0.000166	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS2—kidney cancer	6.83e-06	0.000165	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	6.59e-06	0.000159	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—POMC—kidney cancer	6.55e-06	0.000158	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—BRAF—kidney cancer	6.47e-06	0.000156	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTEN—kidney cancer	6.39e-06	0.000154	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	6.27e-06	0.000151	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	5.99e-06	0.000145	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTEN—kidney cancer	5.96e-06	0.000144	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	5.92e-06	0.000143	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CA—kidney cancer	5.66e-06	0.000137	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	5.44e-06	0.000131	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RAF1—kidney cancer	5.4e-06	0.00013	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RELA—kidney cancer	5.38e-06	0.00013	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	5.35e-06	0.000129	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MTOR—kidney cancer	5.27e-06	0.000127	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	4.95e-06	0.000119	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL2—kidney cancer	4.84e-06	0.000117	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCND1—kidney cancer	4.72e-06	0.000114	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JUN—kidney cancer	4.71e-06	0.000114	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	4.68e-06	0.000113	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTEN—kidney cancer	4.56e-06	0.00011	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CA—kidney cancer	4.51e-06	0.000109	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CA—kidney cancer	4.2e-06	0.000101	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	4.12e-06	9.93e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	3.89e-06	9.4e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MYC—kidney cancer	3.79e-06	9.14e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	3.71e-06	8.94e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KRAS—kidney cancer	3.5e-06	8.44e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	3.22e-06	7.76e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TP53—kidney cancer	3.11e-06	7.51e-05	CbGpPWpGaD
